top of page
Search


Assessment of FucosylGM1 expression in small cell lung carcinoma via antibody (SC134) binding
Assessment of FucosylGM1 expression in small cell lung carcinoma via antibody (SC134) binding
Glenn Hearson
Jun 19, 2024
112


New £9.4m national research centre will improve tests and treatments for rare lung diseases
New £9.4m national research centre will improve tests and treatments for lung diseases
Glenn Hearson
Apr 25, 2024
71


Non-invasive Monitoring for non-invasive ventilation: Use of transcutaneous carbon dioxide monitoring: The REACT-CO2 Study
We have recently commenced a new randomised clinical trial led by Dr Milind Sovani at NUH with funding from Radiometer using a skin...
Glenn Hearson
Jan 5, 2024
277


Efficacy and Safety of Orvepitant in Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis
We have recently commenced a new study led at Nottingham University Hospitals NHS Trust by Gr Gauri Saini, to assess the efficacy and...
Glenn Hearson
Nov 17, 2023
116


Physiological and environmental data in a remote setting to predict exacerbation events in COPD
We have recently commenced a new study, led at Nottingham University Hospital NHS Trust by Dr Matthew Martin, to monitor around 300...
Glenn Hearson
Nov 17, 2023
49


C-FIND COPD Study Featured on BBC Radio Nottingham Sarah Julian Show
Thanks to @BBCNottingham and @mariarubiomedia for joining us today at our mobile research unit at Morrisons supermarket in Clifton...
Glenn Hearson
Nov 10, 2023
127


Continuous respiratory rate and pulse oximetry monitoring using wearable sensors (RespiraSense)
We have recently commenced a new clinical trial testing a new device called RespiraSense which is worn on a patients chest and measures...
Glenn Hearson
Sep 6, 2023
148


COPD Case Finding In Nottingham and District: C-FIND COPD A Pilot study
We have now commenced a new research study supported by the NIHR Nottingham Biomedical Research Centre , NIHR Nottingham Clinical...
Glenn Hearson
Aug 21, 2023
172
bottom of page